After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot ...
RFK Jr.'s attacks on vaccines go beyond changing the childhood immunization schedule. Now he's taking aim at vaccine R&D ...
THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
In its main clinical trial, mRNA-1010 was shown to be 26.6% more effective than the comparator flu shot in adults aged 50 ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Moderna’s updated COVID-19 mRNA vaccine, Spikevax targeting the SARS-CoV-2 LP.8.1 variant, for adults and children aged ...
The US Food and Drug Administration's (FDA’s) Center for Biologics Evaluation and Research (CBER) is refusing to review Moderna’s application for approval of a new flu vaccine. The decision comes ...
As Illinois experiences its most severe flu season in over a decade, public health officials report rising hospitalizations and lower ...
Moderna will continue to lead clinical development and manufacturing for mRNA-3927Moderna to receive up to $160 million ...
Mayo Clinic on MSN
COVID-19 vaccines: Get the facts
Find out about the COVID-19 vaccines, the benefits of COVID-19 vaccination and the possible side effects.
MedPage Today on MSN
How Last Season's COVID Shots Fared Against Severe Disease, Death
Sustained protection through 6 months, but effectiveness slipped as newer strains emerged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results